Enhancer Reprogramming within Pre-existing Topologically Associated Domains Promotes TGF-β-Induced EMT and Cancer Metastasis

Yunbo Qiao,Zejian Wang,Fangzhi Tan,Jun Chen,Jianxiang Lin,Jie Yang,Hui Li,Xiongjun Wang,Andrej Sali,Liye Zhang,Guisheng Zhong

DOI: https://doi.org/10.1016/j.ymthe.2020.05.026

IF: 12.91

2020-09-01

Molecular Therapy

Abstract:<p>TGFβ signaling-triggered epithelial-to-mesenchymal transition (EMT) process is associated with tumor stemness, metastasis, and chemotherapy resistance. However, the epigenomic basis for TGFβ-induced EMT remains largely unknown. Here we reveal that HDAC1-mediated global histone deacetylation and the gain of specific H3K27ac-marked enhancers are essential for the TGFβ-induced EMT process. Enhancers gained upon TGFβ treatment are linked to gene activation of EMT markers and cancer metastasis. Notably, dynamic enhancer gain or loss mainly occurs within pre-existing topologically associated domains (TADs) in epithelial cells, with minimal three-dimensional (3D) genome architecture reorganization. Through motif enrichment analysis of enhancers that are lost or gained upon TGFβ stimulation, we identify FOXA2 as a key factor to activate epithelial-specific enhancer activity, and we also find that TEAD4 forms a complex with SMAD2/3 to mediate TGFβ signaling-triggered mesenchymal enhancer reprogramming. Together, our results implicate that key transcription factor (TF)-mediated enhancer reprogramming modulates the developmental transition in TGFβ signaling-associated cancer metastasis.</p>

genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology